KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,903,325 | +103.8% | 718,423 | +156.9% | 0.27% | +102.3% |
| Q2 2023 | $11,238,386 | +32.8% | 279,701 | +41.2% | 0.13% | +15.7% |
| Q1 2023 | $8,460,535 | -10.4% | 198,139 | +0.7% | 0.12% | -8.7% |
| Q4 2022 | $9,445,486 | -26.7% | 196,699 | -42.6% | 0.13% | -30.0% |
| Q3 2022 | $12,885,000 | -7.9% | 342,493 | +33.2% | 0.18% | -20.7% |
| Q1 2022 | $13,987,000 | +213.7% | 257,200 | +237.5% | 0.23% | +254.7% |
| Q4 2021 | $4,459,000 | -40.0% | 76,212 | -59.4% | 0.06% | -47.1% |
| Q3 2021 | $7,431,000 | – | 187,835 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 321,300 | $12,087,000 | 4.99% |
| First Light Asset Management, LLC | 598,213 | $22,505,000 | 2.28% |
| Nantahala Capital Management | 845,692 | $31,815,000 | 2.06% |
| CHI Advisors LLC | 200,229 | $7,533,000 | 2.03% |
| Fairmount Funds Management LLC | 272,498 | $10,251,000 | 1.80% |
| Altium Capital Management LP | 88,000 | $3,311,000 | 1.21% |
| Orbimed Advisors | 1,679,417 | $63,180,000 | 1.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,819 | $7,781,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,927 | $3,759,000 | 1.07% |
| Soleus Capital Management, L.P. | 146,000 | $5,493,000 | 0.75% |